Arslan Tariq, Masroor Sagheer, Zachary K Seekford, Junxiao Ren, Feng Yue, John J Bromfield
Abstract: With rising global temperatures, it is imperative to determine the impact of heat stress on the physiology of food producing animals. Dairy cows are susceptible to uterine diseases that reduce fertility. Immune function is important in the development and progression of disease; however, the effect of heat shock on the innate immune capacity of endometrial epithelial cells remains underexplored. Here, we investigated how heat shock alters the innate immune response and mitochondrial respiration of bovine endometrial epithelial cells. Primary endometrial epithelial cells were collected from postpartum cows and cultured in the presence of lipopolysaccharide under thermoneutral (38.5°C) or heat shock (40.5°C) conditions. Time-course and sequential heat shock experiments were conducted to assess gene expression dynamics of HSPA1A, TLR4, CXCL8, IL6, and IL1B. Cell viability was evaluated by MTT assay, and mitochondrial respiration was analyzed using high-resolution respirometry. Heat shock did not affect cell viability or overall mitochondrial respiration but reduced proton leak-related oxygen consumption. Acute heat shock induced HSPA1A expression but suppressed LPS-stimulated CXCL8 and IL6 expression. Expression of TLR4 increased when cells were recovering from heat shock or following sequential heat shock. Sequential heat shock did not affect the expression of proinflammatory mediators compared to a single heat shock event. In conclusion, acute heat shock of bovine endometrial epithelial cells reduced the innate immune response to LPS without impacting cell viability or mitochondrial function. Altered endometrial immune function may contribute to the increased incidence of uterine diseases in cows under heat stress conditions.
Lay summary: As global temperatures continue to rise, food producing animals face increasing challenges to their fertility and productivity. Uterine disease in dairy cows reduces fertility and impacts milk production. Heat stress is known to disrupt immune function, but less is understood about how elevated temperatures affect the cells that line the uterus that respond to invading pathogens. We examined how acute heat exposure affects the immune response of uterine cells to respond to pathogens and found that heat shock reduces their ability to produce key immune molecules needed to fight bacteria. This suggests that heat stress directly weakens the natural defenses of the uterus and helps us understand why cows are vulnerable to reproductive diseases during hot weather. Understanding these effects can guide better management strategies to protect animal health in a warming climate.
{"title":"Heat shock suppresses innate immune response of bovine endometrial epithelial cells.","authors":"Arslan Tariq, Masroor Sagheer, Zachary K Seekford, Junxiao Ren, Feng Yue, John J Bromfield","doi":"10.1530/RAF-25-0213","DOIUrl":"https://doi.org/10.1530/RAF-25-0213","url":null,"abstract":"<p><strong>Abstract: </strong>With rising global temperatures, it is imperative to determine the impact of heat stress on the physiology of food producing animals. Dairy cows are susceptible to uterine diseases that reduce fertility. Immune function is important in the development and progression of disease; however, the effect of heat shock on the innate immune capacity of endometrial epithelial cells remains underexplored. Here, we investigated how heat shock alters the innate immune response and mitochondrial respiration of bovine endometrial epithelial cells. Primary endometrial epithelial cells were collected from postpartum cows and cultured in the presence of lipopolysaccharide under thermoneutral (38.5°C) or heat shock (40.5°C) conditions. Time-course and sequential heat shock experiments were conducted to assess gene expression dynamics of HSPA1A, TLR4, CXCL8, IL6, and IL1B. Cell viability was evaluated by MTT assay, and mitochondrial respiration was analyzed using high-resolution respirometry. Heat shock did not affect cell viability or overall mitochondrial respiration but reduced proton leak-related oxygen consumption. Acute heat shock induced HSPA1A expression but suppressed LPS-stimulated CXCL8 and IL6 expression. Expression of TLR4 increased when cells were recovering from heat shock or following sequential heat shock. Sequential heat shock did not affect the expression of proinflammatory mediators compared to a single heat shock event. In conclusion, acute heat shock of bovine endometrial epithelial cells reduced the innate immune response to LPS without impacting cell viability or mitochondrial function. Altered endometrial immune function may contribute to the increased incidence of uterine diseases in cows under heat stress conditions.</p><p><strong>Lay summary: </strong>As global temperatures continue to rise, food producing animals face increasing challenges to their fertility and productivity. Uterine disease in dairy cows reduces fertility and impacts milk production. Heat stress is known to disrupt immune function, but less is understood about how elevated temperatures affect the cells that line the uterus that respond to invading pathogens. We examined how acute heat exposure affects the immune response of uterine cells to respond to pathogens and found that heat shock reduces their ability to produce key immune molecules needed to fight bacteria. This suggests that heat stress directly weakens the natural defenses of the uterus and helps us understand why cows are vulnerable to reproductive diseases during hot weather. Understanding these effects can guide better management strategies to protect animal health in a warming climate.</p>","PeriodicalId":101312,"journal":{"name":"Reproduction & fertility","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146151618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nabil Subhi-Issa, Eduardo de la Fuente-Muñoz, Ángela Villegas-Mendiola, María Palacios-Ortega, Lydia Pilar-Suárez, Marta Calvo, María Guzmán-Fulgencio, Juliana Ochoa-Grullon, Miguel Fernández-Arquero, Ignacio Cristóbal, Silvia Sánchez-Ramón
Recurrent pregnancy loss (RPL) and recurrent implantation failure (RIF) are thought to arise from distinct yet partially overlapping causes, with a substantial number of cases associated with immune system alterations. We hypothesized that a peripheral blood signature integrating natural killer (NK) cell receptor status, monocyte activation, myeloid-derived suppressor cell (MDSC) abundance, and regulatory T cell (TReg) levels would more accurately distinguish each disorder from non-pregnant healthy controls than any single biomarker. We enrolled 194 women and performed deep immunophenotyping of NK cells, monocytes, MDSC, and TReg. Variable selection was performed with the Boruta algorithm, followed by multivariate logistic regression modelling. For RPL, the final model included five biomarkers, achieving an area under the curve of 0.95 and an accuracy of 90.7%. For RIF, the model retained four biomarkers, yielding an area under the curve of 0.85 and an accuracy of 79.5%. Logistic regression was deliberately chosen to prioritize clinical interpretability and facilitate future translation into a point-based diagnostic score.
{"title":"Multivariate model predicts immune imbalance in recurrent pregnancy loss and recurrent implantation failure.","authors":"Nabil Subhi-Issa, Eduardo de la Fuente-Muñoz, Ángela Villegas-Mendiola, María Palacios-Ortega, Lydia Pilar-Suárez, Marta Calvo, María Guzmán-Fulgencio, Juliana Ochoa-Grullon, Miguel Fernández-Arquero, Ignacio Cristóbal, Silvia Sánchez-Ramón","doi":"10.1530/RAF-25-0130","DOIUrl":"https://doi.org/10.1530/RAF-25-0130","url":null,"abstract":"<p><p>Recurrent pregnancy loss (RPL) and recurrent implantation failure (RIF) are thought to arise from distinct yet partially overlapping causes, with a substantial number of cases associated with immune system alterations. We hypothesized that a peripheral blood signature integrating natural killer (NK) cell receptor status, monocyte activation, myeloid-derived suppressor cell (MDSC) abundance, and regulatory T cell (TReg) levels would more accurately distinguish each disorder from non-pregnant healthy controls than any single biomarker. We enrolled 194 women and performed deep immunophenotyping of NK cells, monocytes, MDSC, and TReg. Variable selection was performed with the Boruta algorithm, followed by multivariate logistic regression modelling. For RPL, the final model included five biomarkers, achieving an area under the curve of 0.95 and an accuracy of 90.7%. For RIF, the model retained four biomarkers, yielding an area under the curve of 0.85 and an accuracy of 79.5%. Logistic regression was deliberately chosen to prioritize clinical interpretability and facilitate future translation into a point-based diagnostic score.</p>","PeriodicalId":101312,"journal":{"name":"Reproduction & fertility","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146151625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
<p><strong>Abstract: </strong>Recent evidence suggests a global decline in semen quality, raising significant concerns about male reproductive health. Data from North Africa are limited, and the region faces unique environmental and lifestyle challenges. In addition, the COVID-19 pandemic may have caused transient or lasting effects on male fertility. This retrospective study aimed to evaluate changes in semen quality among North African men between 2019 and 2024, in comparison with data from 2013 to 2018, and to assess the potential impact of the COVID-19 pandemic on sperm parameters. A total of 21,585 semen samples from men aged 19-74 years, originating from three North African countries (Tunisia, Algeria, and Libya), were analyzed. Semen analyses were performed in a Tunisian andrology laboratory in accordance with WHO 5th and 6th edition criteria. The assessed parameters included sperm concentration, motility, morphology, vitality, and DNA integrity. Temporal and regional trends were evaluated and compared to a historical cohort from 2013 to 2018. Sperm concentration and progressive motility showed a marked decline in 2020, coinciding with the first COVID-19 wave (P < 0.001). Although a gradual recovery was noted after 2021, the 2024 values remained lower than those of 2019. Sperm morphology exhibited a continuous decline throughout the study period. Libyan men had the highest median sperm concentration, while Algerians had the lowest. Compared to the 2013-2018 cohort, there was a 27.6% decrease in concentration, a 20.5% reduction in motility, and a drop in normal morphology from 12.1 to 5%. Semen quality among North African men continued to deteriorate between 2019 and 2024, with a temporary accentuation during the COVID-19 pandemic. These findings underscore the multifactorial nature of male fertility decline in the region and highlight the need for preventive public health strategies.</p><p><strong>Lay summary: </strong>Studies show that men's sperm quality is getting worse around the world, which can affect their ability to have children. There is not much information about this in North Africa, a region with special environmental and lifestyle factors. The COVID-19 pandemic might have also influenced men's fertility. This study looked at sperm samples from men in three North African countries between 2019 and 2024 and compared them to samples from 2013 to 2018. The goal was to see if sperm quality changed and if COVID-19 had any effect. The results showed that in 2020, when COVID-19 first appeared, sperm numbers and how well they moved dropped a lot. After 2021, there was some improvement, but sperm quality was still lower in 2024 than before the pandemic. The shape of sperm got worse steadily over the years. Men from Libya had the best sperm counts, while men from Algeria had the lowest. In short, sperm quality in North African men got worse over the years, especially during COVID-19. This shows that many things may be causing this probl
{"title":"Declining semen quality in North Africa: from 2019 to 2024: retrospective multicentric study of 21,585 patients.","authors":"Mustapha Benkhalifa, Wiem Zidi, Marwa Lahimer, Rosalie Cabry, Moncef Benkhalifa, Hatem Bahri","doi":"10.1530/RAF-25-0114","DOIUrl":"10.1530/RAF-25-0114","url":null,"abstract":"<p><strong>Abstract: </strong>Recent evidence suggests a global decline in semen quality, raising significant concerns about male reproductive health. Data from North Africa are limited, and the region faces unique environmental and lifestyle challenges. In addition, the COVID-19 pandemic may have caused transient or lasting effects on male fertility. This retrospective study aimed to evaluate changes in semen quality among North African men between 2019 and 2024, in comparison with data from 2013 to 2018, and to assess the potential impact of the COVID-19 pandemic on sperm parameters. A total of 21,585 semen samples from men aged 19-74 years, originating from three North African countries (Tunisia, Algeria, and Libya), were analyzed. Semen analyses were performed in a Tunisian andrology laboratory in accordance with WHO 5th and 6th edition criteria. The assessed parameters included sperm concentration, motility, morphology, vitality, and DNA integrity. Temporal and regional trends were evaluated and compared to a historical cohort from 2013 to 2018. Sperm concentration and progressive motility showed a marked decline in 2020, coinciding with the first COVID-19 wave (P < 0.001). Although a gradual recovery was noted after 2021, the 2024 values remained lower than those of 2019. Sperm morphology exhibited a continuous decline throughout the study period. Libyan men had the highest median sperm concentration, while Algerians had the lowest. Compared to the 2013-2018 cohort, there was a 27.6% decrease in concentration, a 20.5% reduction in motility, and a drop in normal morphology from 12.1 to 5%. Semen quality among North African men continued to deteriorate between 2019 and 2024, with a temporary accentuation during the COVID-19 pandemic. These findings underscore the multifactorial nature of male fertility decline in the region and highlight the need for preventive public health strategies.</p><p><strong>Lay summary: </strong>Studies show that men's sperm quality is getting worse around the world, which can affect their ability to have children. There is not much information about this in North Africa, a region with special environmental and lifestyle factors. The COVID-19 pandemic might have also influenced men's fertility. This study looked at sperm samples from men in three North African countries between 2019 and 2024 and compared them to samples from 2013 to 2018. The goal was to see if sperm quality changed and if COVID-19 had any effect. The results showed that in 2020, when COVID-19 first appeared, sperm numbers and how well they moved dropped a lot. After 2021, there was some improvement, but sperm quality was still lower in 2024 than before the pandemic. The shape of sperm got worse steadily over the years. Men from Libya had the best sperm counts, while men from Algeria had the lowest. In short, sperm quality in North African men got worse over the years, especially during COVID-19. This shows that many things may be causing this probl","PeriodicalId":101312,"journal":{"name":"Reproduction & fertility","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146069310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
<p><strong>Graphical abstract: </strong></p><p><strong>Abstract: </strong>Polycystic ovary syndrome (PCOS) is a complex reproductive-endocrine disorder characterized by impaired folliculogenesis, anovulation, and hormonal imbalance. While PNX-14 is known as a hypothalamic peptide that modulates GnRH signaling, emerging evidence indicates its local ovarian expression, particularly in granulosa and luteal cells, suggesting potential peripheral roles in follicular development. This study aimed to evaluate the therapeutic potential of PNX-14 in a dehydroepiandrosterone (DHEA)-induced rat model of PCOS, with a focus on its potential peripheral effects on ovarian tissue. Female rats were divided into control, PCOS, and PCOS + PNX-14 (2.5, 5, or 30 nmol) groups. PCOS was induced by DHEA administration (60 mg/kg/day, s.c.) for 21 days. Vaginal cytology, hormone assays (FSH, LH, E2, P4, and testosterone), histological analysis, PCNA immunohistochemistry, and western blot were performed. DHEA-induced PCOS rats exhibited disrupted estrous cycles, suppressed gonadotropins and estradiol, and polycystic ovarian morphology with extensive follicular atresia and reduced PCNA expression. PNX-14 treatment, particularly at 5 nmol, significantly improved estrous cyclicity, restored primordial and antral follicle populations, reduced atretic and cystic follicles, and normalized PCNA levels in granulosa cells. Serum hormones showed trends toward recovery without consistent statistical significance after 3 days of treatment. This study provides the first in vivo evidence that peripheral administration of this peptide ameliorates key morphological and cellular features of PCOS in rats, primarily by enhancing granulosa cell proliferation and early folliculogenesis. These findings support further investigation into PNX-14 as a novel therapeutic candidate as a local ovarian modulator for PCOS, potentially offering disease-modifying effects beyond conventional symptom-targeted therapies.</p><p><strong>Lay summary: </strong>PCOS is a leading cause of infertility and affects millions of women worldwide. It disrupts normal egg development, causing hormonal imbalances and cyst formation in the ovaries. Current treatments mainly control symptoms but do not repair the ovary itself. We investigate PNX-14, a natural peptide present in the brain and ovary that supports early egg growth. We tested this peptide found in the brain and ovary that supports early egg growth, in a well-established rat model of PCOS. After three days of treatment, it improved ovarian structure and restored regular reproductive cycling. Importantly, it significantly reduced degenerating follicles, helping to preserve healthy early-stage follicles. These benefits occurred even though major blood hormone levels were largely unchanged, suggesting that this peptide acts locally within the ovary. This is the first in vivo evidence that it can directly counter key cellular and structural damage caused by PCOS. The
{"title":"Phoenixin-14 ameliorates ovarian morphology in a DHEA-induced rat model of PCOS.","authors":"Miray Berber, Gonca Topal, Asligul Bulut, Gulce Sevdar Cecen, Habibe Goren, Gamze Guney Eskiler, Zulfiye Gul, Duygu Gok Yurtseven","doi":"10.1530/RAF-25-0142","DOIUrl":"10.1530/RAF-25-0142","url":null,"abstract":"<p><strong>Graphical abstract: </strong></p><p><strong>Abstract: </strong>Polycystic ovary syndrome (PCOS) is a complex reproductive-endocrine disorder characterized by impaired folliculogenesis, anovulation, and hormonal imbalance. While PNX-14 is known as a hypothalamic peptide that modulates GnRH signaling, emerging evidence indicates its local ovarian expression, particularly in granulosa and luteal cells, suggesting potential peripheral roles in follicular development. This study aimed to evaluate the therapeutic potential of PNX-14 in a dehydroepiandrosterone (DHEA)-induced rat model of PCOS, with a focus on its potential peripheral effects on ovarian tissue. Female rats were divided into control, PCOS, and PCOS + PNX-14 (2.5, 5, or 30 nmol) groups. PCOS was induced by DHEA administration (60 mg/kg/day, s.c.) for 21 days. Vaginal cytology, hormone assays (FSH, LH, E2, P4, and testosterone), histological analysis, PCNA immunohistochemistry, and western blot were performed. DHEA-induced PCOS rats exhibited disrupted estrous cycles, suppressed gonadotropins and estradiol, and polycystic ovarian morphology with extensive follicular atresia and reduced PCNA expression. PNX-14 treatment, particularly at 5 nmol, significantly improved estrous cyclicity, restored primordial and antral follicle populations, reduced atretic and cystic follicles, and normalized PCNA levels in granulosa cells. Serum hormones showed trends toward recovery without consistent statistical significance after 3 days of treatment. This study provides the first in vivo evidence that peripheral administration of this peptide ameliorates key morphological and cellular features of PCOS in rats, primarily by enhancing granulosa cell proliferation and early folliculogenesis. These findings support further investigation into PNX-14 as a novel therapeutic candidate as a local ovarian modulator for PCOS, potentially offering disease-modifying effects beyond conventional symptom-targeted therapies.</p><p><strong>Lay summary: </strong>PCOS is a leading cause of infertility and affects millions of women worldwide. It disrupts normal egg development, causing hormonal imbalances and cyst formation in the ovaries. Current treatments mainly control symptoms but do not repair the ovary itself. We investigate PNX-14, a natural peptide present in the brain and ovary that supports early egg growth. We tested this peptide found in the brain and ovary that supports early egg growth, in a well-established rat model of PCOS. After three days of treatment, it improved ovarian structure and restored regular reproductive cycling. Importantly, it significantly reduced degenerating follicles, helping to preserve healthy early-stage follicles. These benefits occurred even though major blood hormone levels were largely unchanged, suggesting that this peptide acts locally within the ovary. This is the first in vivo evidence that it can directly counter key cellular and structural damage caused by PCOS. The ","PeriodicalId":101312,"journal":{"name":"Reproduction & fertility","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146069251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-29Print Date: 2026-01-01DOI: 10.1530/RAF-25-0074
Lindsey Marie Vansandt, Cristina Harumi Adania, Priscila Rocha Yanai, Jéssica da Silva Paulino, Regina Celia Rodrigues da Paz, Helen L Bateman, Elizabeth Marie Donelan, William F Swanson
Abstract: The jaguar faces significant threats to survival from habitat fragmentation/loss and poaching. Conservation efforts include maintaining ex situ populations in zoos, but breeding success remains limited, necessitating the development of assisted reproductive technologies. This study aimed to optimize ovarian synchronization and artificial insemination (AI) protocols for jaguars by evaluating ovarian follicular activity during oral altrenogest treatment and in response to equine chorionic gonadotropin (eCG)/porcine luteinizing hormone (pLH) regimens, and assessing fertility outcomes with laparoscopic AI. In experiment 1, females were fed altrenogest (0.044 or 0.088 mg/kg, n = 2 per dose) daily for 45 days, but neither dose suppressed ovarian activity. In experiment 2, females received 0.088 or 0.176 mg/kg altrenogest (n = 2 per dose) for 45-48 days and then the alternate dose six months later. After a 5-day withdrawal, 600 IU eCG and 5,000 IU pLH (82 h interval) were administered intramuscularly. All eight cycles produced multiple follicles, but ovulation rates were low and no pregnancies occurred. In experiment 3, five females received 0.176 mg/kg altrenogest, followed by a 7-day withdrawal, 600 IU eCG, and 10,000 IU pLH (90-92 h interval). All females achieved multiple ovulations, and one female conceived, delivering a live cub after 103 days - the first jaguar ever produced from AI. In summary, altrenogest and eCG/pLH treatment following species-specific adjustments was effective for ovarian synchronization in the jaguar. The birth of a live cub following AI validates the effectiveness of this hormone regimen and highlights the potential of AI for population management of this imperiled felid.
美洲虎面临着栖息地破碎/丧失和偷猎对其生存的重大威胁。保护工作包括在动物园里维持非原生境种群,但繁殖成功仍然有限,这就需要发展辅助生殖技术。本研究旨在通过评估口服异丙肾上腺素治疗期间和马绒毛膜促性腺激素(eCG)/猪黄体生成素(pLH)方案对美洲豹卵巢卵泡活性的反应,以及腹腔镜人工授精评估生育结果,优化卵巢同步和人工授精(AI)方案。在试验1中,雌性小鼠每天饲喂0.044或0.088 mg/kg, n = 2次/剂量,连续45 d,均未抑制卵巢活性。实验2中,雌性分别给予0.088或0.176 mg/kg阿立诺酯(n = 2次/剂量)治疗45-48天,6个月后再进行交替治疗。停药5天后,肌内给予600 IU eCG和5000 IU pLH(间隔82小时)。所有8个周期均产生多个卵泡,但排卵率较低,未发生妊娠。在实验3中,5名女性服用0.176 mg/kg阿立诺酯,随后停药7天,心电图600 IU, pLH 10000 IU(间隔90-92小时)。所有雌性美洲虎都进行了多次排卵,其中一只雌性美洲虎在103天后怀孕,产下了一只活着的幼崽——这是有史以来第一只人工智能美洲虎。总之,阿替诺司和eCG/pLH治疗在物种特异性调整后,对美洲虎卵巢同步是有效的。人工智能后的幼崽的出生验证了这种激素疗法的有效性,并突出了人工智能在这种濒危猫科动物种群管理方面的潜力。
{"title":"Optimizing fixed-time laparoscopic artificial insemination in the jaguar.","authors":"Lindsey Marie Vansandt, Cristina Harumi Adania, Priscila Rocha Yanai, Jéssica da Silva Paulino, Regina Celia Rodrigues da Paz, Helen L Bateman, Elizabeth Marie Donelan, William F Swanson","doi":"10.1530/RAF-25-0074","DOIUrl":"10.1530/RAF-25-0074","url":null,"abstract":"<p><strong>Abstract: </strong>The jaguar faces significant threats to survival from habitat fragmentation/loss and poaching. Conservation efforts include maintaining ex situ populations in zoos, but breeding success remains limited, necessitating the development of assisted reproductive technologies. This study aimed to optimize ovarian synchronization and artificial insemination (AI) protocols for jaguars by evaluating ovarian follicular activity during oral altrenogest treatment and in response to equine chorionic gonadotropin (eCG)/porcine luteinizing hormone (pLH) regimens, and assessing fertility outcomes with laparoscopic AI. In experiment 1, females were fed altrenogest (0.044 or 0.088 mg/kg, n = 2 per dose) daily for 45 days, but neither dose suppressed ovarian activity. In experiment 2, females received 0.088 or 0.176 mg/kg altrenogest (n = 2 per dose) for 45-48 days and then the alternate dose six months later. After a 5-day withdrawal, 600 IU eCG and 5,000 IU pLH (82 h interval) were administered intramuscularly. All eight cycles produced multiple follicles, but ovulation rates were low and no pregnancies occurred. In experiment 3, five females received 0.176 mg/kg altrenogest, followed by a 7-day withdrawal, 600 IU eCG, and 10,000 IU pLH (90-92 h interval). All females achieved multiple ovulations, and one female conceived, delivering a live cub after 103 days - the first jaguar ever produced from AI. In summary, altrenogest and eCG/pLH treatment following species-specific adjustments was effective for ovarian synchronization in the jaguar. The birth of a live cub following AI validates the effectiveness of this hormone regimen and highlights the potential of AI for population management of this imperiled felid.</p>","PeriodicalId":101312,"journal":{"name":"Reproduction & fertility","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145992595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Abstract: Prepubertal exposure to gonadotoxic chemotherapy, such as cyclophosphamide (CY), poses a significant risk to long-term fertility by depleting ovarian reserve and impairing oocyte quality. Such treatments are commonly administered to young girls with cancer, and when these individuals later seek assisted reproductive technologies (ARTs), concerns arise regarding the developmental competence and cryotolerance of resulting embryos. Using a mouse model, this study evaluated the impact of prepubertal CY exposure (2 successive weekly doses of 75 mg/kg body weight at 2 weeks of age) on the cryosusceptibility of embryos derived via in vitro fertilization (IVF) at their reproductive phase. Oocytes were collected from superovulated females six weeks post-CY treatment and fertilized in vitro, and the resulting cleavage stage embryos were subjected to vitrification-warming. Embryo survival and quality were assessed by blastocyst formation, inner cell mass (ICM) proliferation in vitro, and the expression of key pluripotency markers (Oct4, Sox2, and Nanog). Results showed no significant differences between CY-exposed and control groups in terms of post-warming survival or marker expression. These findings suggest that maternal CY exposure during the prepubertal period does not adversely affect the cryo-resilience of IVF-derived embryos, offering reassurance for childhood cancer survivors seeking ART treatment.
Lay summary: Chemotherapy given during childhood can harm future fertility, especially in girls who have not yet gone through puberty. One common chemotherapy drug, cyclophosphamide (CY), may reduce the number and quality of eggs in the ovaries. Cancer survivors may be more likely to need IVF (in vitro fertilization) or other fertility treatments, given the impact of the treatment on their fertility. In this study, a mouse model was used to understand whether early-life exposure to CY affects the ability of embryos (created through IVF) to survive freezing and thawing, a common part of IVF treatments. The study found that embryos from mice exposed to CY before puberty survived the freezing process just as well as those from unexposed mice. The quality and health of these embryos, measured by their development and important growth markers, were also similar. These findings provide hopeful news for young girls who receive certain types of chemotherapy, who may still have the option to use IVF in the future without increased risk of embryo damage during freezing.
{"title":"Maternal exposure to cyclophosphamide during prepubertal life does not affect the cryosusceptibility of in vitro derived mouse embryos.","authors":"Dhakshanya Predheepan, Sujith Raj Salian, Akshatha Daddangadi, Shubhashree Uppangala, Guruprasad Kalthur, Borut Kovačič, Satish Kumar Adiga","doi":"10.1530/RAF-25-0153","DOIUrl":"10.1530/RAF-25-0153","url":null,"abstract":"<p><strong>Abstract: </strong>Prepubertal exposure to gonadotoxic chemotherapy, such as cyclophosphamide (CY), poses a significant risk to long-term fertility by depleting ovarian reserve and impairing oocyte quality. Such treatments are commonly administered to young girls with cancer, and when these individuals later seek assisted reproductive technologies (ARTs), concerns arise regarding the developmental competence and cryotolerance of resulting embryos. Using a mouse model, this study evaluated the impact of prepubertal CY exposure (2 successive weekly doses of 75 mg/kg body weight at 2 weeks of age) on the cryosusceptibility of embryos derived via in vitro fertilization (IVF) at their reproductive phase. Oocytes were collected from superovulated females six weeks post-CY treatment and fertilized in vitro, and the resulting cleavage stage embryos were subjected to vitrification-warming. Embryo survival and quality were assessed by blastocyst formation, inner cell mass (ICM) proliferation in vitro, and the expression of key pluripotency markers (Oct4, Sox2, and Nanog). Results showed no significant differences between CY-exposed and control groups in terms of post-warming survival or marker expression. These findings suggest that maternal CY exposure during the prepubertal period does not adversely affect the cryo-resilience of IVF-derived embryos, offering reassurance for childhood cancer survivors seeking ART treatment.</p><p><strong>Lay summary: </strong>Chemotherapy given during childhood can harm future fertility, especially in girls who have not yet gone through puberty. One common chemotherapy drug, cyclophosphamide (CY), may reduce the number and quality of eggs in the ovaries. Cancer survivors may be more likely to need IVF (in vitro fertilization) or other fertility treatments, given the impact of the treatment on their fertility. In this study, a mouse model was used to understand whether early-life exposure to CY affects the ability of embryos (created through IVF) to survive freezing and thawing, a common part of IVF treatments. The study found that embryos from mice exposed to CY before puberty survived the freezing process just as well as those from unexposed mice. The quality and health of these embryos, measured by their development and important growth markers, were also similar. These findings provide hopeful news for young girls who receive certain types of chemotherapy, who may still have the option to use IVF in the future without increased risk of embryo damage during freezing.</p>","PeriodicalId":101312,"journal":{"name":"Reproduction & fertility","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145992598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
MengDan Xi, HongYi Xu, XiaoNing Wang, JiaRong Tian, Min Lu, HongTao Zheng, Li He, Ying Zhang
With the gradual emergence of population issues and the increasing incidence of infertility, the role of assisted reproductive technology (ART) is becoming increasingly important. Accurately, objectively, and comprehensively assessing the blastocyst formation rate and predicting delivery outcomes are urgent problems to be solved. This study retrospectively analyzed the clinical data of patients who underwent ART at Renmin Hospital, Hubei University of Medicine, from June 2017 to January 2020. A regression model for the blastocyst formation rate was established through regression analysis. The results showed that late-stage indicators in ART had a significant impact on the blastocyst formation rate, with top-quality embryos having the greatest effect. A discriminant analysis model for delivery outcome was established. It correctly classified 80.4% of the original grouped cases and 79.6% of the cross-validated grouped cases. the area under the receiver operating characteristic curve (AUROC) was 0.887, indicating that the discriminant model has relatively high predictive diagnostic value. Analysis revealed that blood hCG(human chorionic gonadotropin) results play a crucial role in discriminant analysis model. Additionally, the number of top-quality embryos and the blastocyst formation rate also have a significant impact on the accurate prediction of delivery outcomes. Through analyzing the regression model, we propose exploring early blood markers that can predict the blastocyst formation rate. Simultaneously, a new discriminant model that can directly predict the final delivery outcomes was established.
{"title":"Establishment and Application of a Prediction Model for Blastocyst Formation Rate and Delivery Outcome in Human Assisted Reproductive Technology.","authors":"MengDan Xi, HongYi Xu, XiaoNing Wang, JiaRong Tian, Min Lu, HongTao Zheng, Li He, Ying Zhang","doi":"10.1530/RAF-25-0021","DOIUrl":"https://doi.org/10.1530/RAF-25-0021","url":null,"abstract":"<p><p>With the gradual emergence of population issues and the increasing incidence of infertility, the role of assisted reproductive technology (ART) is becoming increasingly important. Accurately, objectively, and comprehensively assessing the blastocyst formation rate and predicting delivery outcomes are urgent problems to be solved. This study retrospectively analyzed the clinical data of patients who underwent ART at Renmin Hospital, Hubei University of Medicine, from June 2017 to January 2020. A regression model for the blastocyst formation rate was established through regression analysis. The results showed that late-stage indicators in ART had a significant impact on the blastocyst formation rate, with top-quality embryos having the greatest effect. A discriminant analysis model for delivery outcome was established. It correctly classified 80.4% of the original grouped cases and 79.6% of the cross-validated grouped cases. the area under the receiver operating characteristic curve (AUROC) was 0.887, indicating that the discriminant model has relatively high predictive diagnostic value. Analysis revealed that blood hCG(human chorionic gonadotropin) results play a crucial role in discriminant analysis model. Additionally, the number of top-quality embryos and the blastocyst formation rate also have a significant impact on the accurate prediction of delivery outcomes. Through analyzing the regression model, we propose exploring early blood markers that can predict the blastocyst formation rate. Simultaneously, a new discriminant model that can directly predict the final delivery outcomes was established.</p>","PeriodicalId":101312,"journal":{"name":"Reproduction & fertility","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146069274","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Zhaoxia Tian, Xia Ren, Wenke Guo, Xiaolong Du, Hongmei Li, Xiwang Hao, Meilian Zhang, Jun Zhang, Ruishan Sheng
Cancer can leave young men worried about whether they can ever become fathers. We asked 365 male patients in Shanxi what shaped these worries. Older, less-educated men with advanced or certain cancer types felt more fear, while those who already had children, earned more money or still wanted children felt calmer. Good social support, better coping skills and strong self-belief lowered fear, whereas avoidance or giving up made it worse. Doctors should offer emotional, social and practical help to ease these concerns.
{"title":"Factors and pathways Influencing Fertility Anxiety in Reproductive-Age Male Cancer Patients: A Stress Process Theory Perspective.","authors":"Zhaoxia Tian, Xia Ren, Wenke Guo, Xiaolong Du, Hongmei Li, Xiwang Hao, Meilian Zhang, Jun Zhang, Ruishan Sheng","doi":"10.1530/RAF-25-0099","DOIUrl":"https://doi.org/10.1530/RAF-25-0099","url":null,"abstract":"<p><p>Cancer can leave young men worried about whether they can ever become fathers. We asked 365 male patients in Shanxi what shaped these worries. Older, less-educated men with advanced or certain cancer types felt more fear, while those who already had children, earned more money or still wanted children felt calmer. Good social support, better coping skills and strong self-belief lowered fear, whereas avoidance or giving up made it worse. Doctors should offer emotional, social and practical help to ease these concerns.</p>","PeriodicalId":101312,"journal":{"name":"Reproduction & fertility","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145992570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-13Print Date: 2026-01-01DOI: 10.1530/RAF-25-0120
Jin Lu, Chenyue Dong, Lu Wang, Peizhe Tian, Cuilian Zhang, Xue Wang
Abstract: Low oocyte retrieval (LOR), defined as oocytes retrieved from <50% of mature follicles, significantly impacts IVF success, especially in patients with diminished ovarian reserve (DOR). Predictive models tailored for this population are limited. This retrospective cohort study developed a predictive nomogram for LOR risk in first-cycle IVF/ICSI patients with DOR. The data from 2,594 eligible patients were analyzed. LOR was defined as oocyte retrieval rate <50% (oocytes/follicles ≥14 mm on trigger day). Least absolute shrinkage and selection operator (LASSO) regression identified predictors from clinical/endocrine parameters. A multivariate logistic model was built, visualized as a nomogram, and internally validated (bootstrap resampling). Performance was assessed via AUC, calibration, and decision curve analysis. Eight independent predictors were identified: age, basal FSH, AFC, AMH, LH on hCG day, progesterone (P) on hCG day, number of large follicles (≥14 mm) on hCG day, and trigger-to-retrieval time (TR-OPU). The model demonstrated moderate yet acceptable discrimination (AUC = 0.721, 95% CI: 0.678-0.772) and calibration. TR-OPU was significantly shorter in the LOR group (34.85 vs 35.05 h, P < 0.001). DCA confirmed clinical utility. This study establishes a clinical-endocrine nomogram predicting LOR risk in first-cycle DOR patients. Incorporating key factors, such as TR-OPU, ovarian reserve markers (AMH, AFC, and bFSH), and trigger-day hormones, it may help stratify risk but requires external validation before clinical application.
Lay summary: Women with naturally lower egg reserves often face extra challenges with IVF. A common problem is retrieving fewer eggs than expected during the procedure ('low oocyte retrieval' or LOR), which significantly lowers the chance of pregnancy. Doctors lack good tools to predict who is most at risk. Our study analyzed data from 2,594 women with low egg reserves undergoing their first IVF cycle. We created a simple prediction chart that combines key information easily available to doctors: the woman's age, standard hormone blood tests (AMH and FSH), an ultrasound count of egg sacs (follicles), hormone levels on the day of the final IVF trigger shot, and critically - the exact number of hours between the trigger and the egg collection surgery. This chart accurately estimates an individual woman's risk of LOR. Knowing this risk beforehand helps doctors personalize treatment timing and medication, aiming to collect more eggs and improve the chances of a successful pregnancy, while helping patients avoid unnecessary emotional and financial strain.
低卵母细胞回收(LOR),定义为从
{"title":"Development of a risk model for low oocyte retrieval in first-cycle IVF patients with diminished ovarian reserve: a retrospective single-center study.","authors":"Jin Lu, Chenyue Dong, Lu Wang, Peizhe Tian, Cuilian Zhang, Xue Wang","doi":"10.1530/RAF-25-0120","DOIUrl":"10.1530/RAF-25-0120","url":null,"abstract":"<p><strong>Abstract: </strong>Low oocyte retrieval (LOR), defined as oocytes retrieved from <50% of mature follicles, significantly impacts IVF success, especially in patients with diminished ovarian reserve (DOR). Predictive models tailored for this population are limited. This retrospective cohort study developed a predictive nomogram for LOR risk in first-cycle IVF/ICSI patients with DOR. The data from 2,594 eligible patients were analyzed. LOR was defined as oocyte retrieval rate <50% (oocytes/follicles ≥14 mm on trigger day). Least absolute shrinkage and selection operator (LASSO) regression identified predictors from clinical/endocrine parameters. A multivariate logistic model was built, visualized as a nomogram, and internally validated (bootstrap resampling). Performance was assessed via AUC, calibration, and decision curve analysis. Eight independent predictors were identified: age, basal FSH, AFC, AMH, LH on hCG day, progesterone (P) on hCG day, number of large follicles (≥14 mm) on hCG day, and trigger-to-retrieval time (TR-OPU). The model demonstrated moderate yet acceptable discrimination (AUC = 0.721, 95% CI: 0.678-0.772) and calibration. TR-OPU was significantly shorter in the LOR group (34.85 vs 35.05 h, P < 0.001). DCA confirmed clinical utility. This study establishes a clinical-endocrine nomogram predicting LOR risk in first-cycle DOR patients. Incorporating key factors, such as TR-OPU, ovarian reserve markers (AMH, AFC, and bFSH), and trigger-day hormones, it may help stratify risk but requires external validation before clinical application.</p><p><strong>Lay summary: </strong>Women with naturally lower egg reserves often face extra challenges with IVF. A common problem is retrieving fewer eggs than expected during the procedure ('low oocyte retrieval' or LOR), which significantly lowers the chance of pregnancy. Doctors lack good tools to predict who is most at risk. Our study analyzed data from 2,594 women with low egg reserves undergoing their first IVF cycle. We created a simple prediction chart that combines key information easily available to doctors: the woman's age, standard hormone blood tests (AMH and FSH), an ultrasound count of egg sacs (follicles), hormone levels on the day of the final IVF trigger shot, and critically - the exact number of hours between the trigger and the egg collection surgery. This chart accurately estimates an individual woman's risk of LOR. Knowing this risk beforehand helps doctors personalize treatment timing and medication, aiming to collect more eggs and improve the chances of a successful pregnancy, while helping patients avoid unnecessary emotional and financial strain.</p>","PeriodicalId":101312,"journal":{"name":"Reproduction & fertility","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12820938/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145795890","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-12Print Date: 2026-01-01DOI: 10.1530/RAF-25-0132
Tal Raz, Hunter Alan Warick, Stav Asulin-Schnaiderman, Nuphar Shidlovsky, Nathalie Weizmann, Lee Koren
Abstract: Seasonal reproduction is common among wild mammals, but male fertility traits are often understudied. The rock hyrax (Procavia capensis) is a seasonal breeder with a narrow reproductive window, yet its semen characteristics and seasonal variation remain poorly understood. Our objectives were to develop and validate an electroejaculation protocol for semen collection, and to enable, for the first time, in vivo assessments of sperm morphology, ultrastructure, morphometry, and seasonal variation in semen quality in both captive and wild populations. A total of 70 semen collection attempts were conducted: 17 in captive males at approximately monthly intervals over 1 year and 53 in wild males just before peak mating season and again 2-4 weeks later, across 3 consecutive years (2021-2023). Electroejaculation was well tolerated and effective, particularly around the mating season, eliciting consistent responses and yielding sperm-containing ejaculates in 88.7% of wild procedures. Sperm morphometry revealed a mean total length of ∼56 µm, with ultrastructural features resembling other eutherian mammals. Seasonal analysis demonstrated significantly higher sperm concentration, motility, and normal morphology during peak mating season compared to later samples. Post-peak samples showed increased structural abnormalities, including midpiece and principal piece defects, and signs of disrupted spermatogenesis and epididymal maturation. Cytology and high-resolution scanning electron microscopy confirmed these findings, revealing compromised sperm integrity and elevated round cell counts outside the breeding peak. This study establishes the first in vivo semen collection protocol and comprehensive semen evaluation in the rock hyrax, revealing seasonal variation in male fertility and enabling repeatable, non-lethal reproductive monitoring.
Lay summary: Male fertility traits are poorly characterized in most wild mammals. The rock hyrax (also known as rock rabbit) is a seasonal breeder with a short mating period each year, but little was known about its male reproductive physiology because semen studies relied on post-mortem material. We established a non-lethal protocol for semen collection in rock hyraxes and applied it both in captivity and under natural desert conditions. This enabled detailed analyses of sperm's shape (morphology), architecture (ultrastructure), and dimensions (morphometry), and seasonal semen changes. We found that sperm concentration, motility, and normal morphology were highest during peak breeding season but declined sharply only a few weeks later, accompanied by structural abnormalities and signs of disrupted spermatogenesis. Our study reveals sharp seasonal shifts in male fertility and demonstrates a safe, repeatable method for studying reproduction in wild mammals, with potential applications in conservation and comparative studies among seasonal species.
{"title":"In vivo semen characterization and seasonal variation in Procavia capensis.","authors":"Tal Raz, Hunter Alan Warick, Stav Asulin-Schnaiderman, Nuphar Shidlovsky, Nathalie Weizmann, Lee Koren","doi":"10.1530/RAF-25-0132","DOIUrl":"10.1530/RAF-25-0132","url":null,"abstract":"<p><strong>Abstract: </strong>Seasonal reproduction is common among wild mammals, but male fertility traits are often understudied. The rock hyrax (Procavia capensis) is a seasonal breeder with a narrow reproductive window, yet its semen characteristics and seasonal variation remain poorly understood. Our objectives were to develop and validate an electroejaculation protocol for semen collection, and to enable, for the first time, in vivo assessments of sperm morphology, ultrastructure, morphometry, and seasonal variation in semen quality in both captive and wild populations. A total of 70 semen collection attempts were conducted: 17 in captive males at approximately monthly intervals over 1 year and 53 in wild males just before peak mating season and again 2-4 weeks later, across 3 consecutive years (2021-2023). Electroejaculation was well tolerated and effective, particularly around the mating season, eliciting consistent responses and yielding sperm-containing ejaculates in 88.7% of wild procedures. Sperm morphometry revealed a mean total length of ∼56 µm, with ultrastructural features resembling other eutherian mammals. Seasonal analysis demonstrated significantly higher sperm concentration, motility, and normal morphology during peak mating season compared to later samples. Post-peak samples showed increased structural abnormalities, including midpiece and principal piece defects, and signs of disrupted spermatogenesis and epididymal maturation. Cytology and high-resolution scanning electron microscopy confirmed these findings, revealing compromised sperm integrity and elevated round cell counts outside the breeding peak. This study establishes the first in vivo semen collection protocol and comprehensive semen evaluation in the rock hyrax, revealing seasonal variation in male fertility and enabling repeatable, non-lethal reproductive monitoring.</p><p><strong>Lay summary: </strong>Male fertility traits are poorly characterized in most wild mammals. The rock hyrax (also known as rock rabbit) is a seasonal breeder with a short mating period each year, but little was known about its male reproductive physiology because semen studies relied on post-mortem material. We established a non-lethal protocol for semen collection in rock hyraxes and applied it both in captivity and under natural desert conditions. This enabled detailed analyses of sperm's shape (morphology), architecture (ultrastructure), and dimensions (morphometry), and seasonal semen changes. We found that sperm concentration, motility, and normal morphology were highest during peak breeding season but declined sharply only a few weeks later, accompanied by structural abnormalities and signs of disrupted spermatogenesis. Our study reveals sharp seasonal shifts in male fertility and demonstrates a safe, repeatable method for studying reproduction in wild mammals, with potential applications in conservation and comparative studies among seasonal species.</p>","PeriodicalId":101312,"journal":{"name":"Reproduction & fertility","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145795920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}